Companies /Healthcare

LTGO

LTGO Biotechnology
$21.77
▼ $0.49 (−2.20%) today
Markets closed · 6:51am ET
Today · % change

Fundamentals

Market Cap
$1.4B
EPS (TTM)
$-1.80
52-Week Range
$17 – $26
Street Target
$52.25

About LTGO

Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction. The company is headquartered in Thousand Oaks, California.

LTGO Coverage